SYRS - Syros Pharmaceuticals After The Orsenix Deal December, 29 2020 01:44 AM Syros Pharmaceuticals Inc. Syros Pharmaceuticals doubled its stock price in 2020. Syros recently acquired SY-2101 from Orsenix. The main value is still in SY-1425 for AML or MDS. For further details see: Syros Pharmaceuticals After The Orsenix Deal